256 related articles for article (PubMed ID: 18294313)
1. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
Ferran M; Gallardo F; Ferrer AM; Salar A; Pérez-Vila E; Juanpere N; Salgado R; Espinet B; Orfao A; Florensa L; Pujol RM
Br J Dermatol; 2008 May; 158(5):1129-33. PubMed ID: 18294313
[TBL] [Abstract][Full Text] [Related]
2. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
Herling M; Jones D
Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
[TBL] [Abstract][Full Text] [Related]
3. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
6. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
[TBL] [Abstract][Full Text] [Related]
7. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
Hamadani M; Magro CM; Porcu P
Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
[No Abstract] [Full Text] [Related]
8. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
Garnache-Ottou F; Feuillard J; Saas P
Br J Haematol; 2007 Feb; 136(4):539-48. PubMed ID: 17367408
[TBL] [Abstract][Full Text] [Related]
9. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
[TBL] [Abstract][Full Text] [Related]
10. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
[TBL] [Abstract][Full Text] [Related]
11. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
[TBL] [Abstract][Full Text] [Related]
12. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
13. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
[TBL] [Abstract][Full Text] [Related]
14. Skin manifestations in CD4+, CD56+ malignancies.
Penven K; Macro M; Salaun V; Comoz F; Reman O; Leroy D; Troussard X; Petrella T; Dompmartin A
Eur J Dermatol; 2003; 13(2):161-5. PubMed ID: 12695132
[TBL] [Abstract][Full Text] [Related]
15. [Blastic plasmacytoid dendritic cell neoplasm - a rare differential diagnosis of neoplastic skin infiltrations associated with systemic symptoms].
Löffler H; Kosely F; Ho AD; Krämer A
Dtsch Med Wochenschr; 2009 Sep; 134(39):1927-30. PubMed ID: 19760552
[TBL] [Abstract][Full Text] [Related]
16. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
Bueno C; Almeida J; Lucio P; Marco J; Garcia R; de Pablos JM; Parreira A; Ramos F; Ruiz-Cabello F; Suarez-Vilela D; San Miguel JF; Orfao A
Haematologica; 2004 Jan; 89(1):58-69. PubMed ID: 14754607
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
19. Minimally differentiated acute myeloid leukaemia revealed by specific cutaneous lesions.
Benucci R; Annessi G; Signoretti S; Simoni R
Br J Dermatol; 1996 Jul; 135(1):119-23. PubMed ID: 8776374
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]